Olema Pharmaceuticals, Inc. OLMA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s EPS (diluted)?
- Olema Pharmaceuticals, Inc. (OLMA) reported EPS (diluted) of -$0.52 in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s EPS (diluted) changed year-over-year?
- Olema Pharmaceuticals, Inc.'s EPS (diluted) decreased by 44.4% year-over-year, from -$0.36 to -$0.52.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s EPS (diluted) has grown at a 0.8% compound annual growth rate (CAGR), from -$1.81 to -$1.87.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.